Loading data for PRFX — first visit, this takes a few seconds.
PRF Technologies Ltd. (PRFX)
NasdaqCM: PRFX
· 即時價格 · USD
0.95
+0.00 (0.00%)
收盤價： Sep 02, 2026, 7:20 PM
股價、關鍵數字和最新消息，都在這一頁。
PRF Technologies Ltd.（PRFX）股價、分析與資料
無可用資料
| 買價 | 0.67 |
| 市值 | 2.92M |
| 營收 (ttm) | 17K |
| 淨利（ttm） | -4.84M |
| 1.04 | |
| -7.47 | |
| n/a | |
| -0.08 | |
| P/B (ttm) | 0.09 |
| P/S (ttm) | 171.79 |
| 財報日期 | n/a |
| 賣價 | 1.23 |
| 成交量 | 20,118 |
| 20 日平均成交量 | 1,337,660 |
| 開盤價 | 0.96 |
| 前收盤價 | 0.95 |
| 當日區間 | 0.94 - 0.96 |
| 52 週範圍 | 0.91 - 9.00 |
| 分析師 | n/a |
| 目標價 | n/a |
| 股利 | n/a |
| 除息日 | n/a |
關於 PRFX
PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in cataract surgery; and PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company was formerly known...
完整的公司簡介財報驚奇
PRF 已於 Aug 15, 2024 公布季度財報：
- 營收為 n/a 低於預期 $0, 年增 NaN% 成長.
- 每股盈餘為 -48 超出預期 76.80, 年增 79.17% 成長.
